Merck & Co Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (203)

View All

Latest Posts

About This Stock More About This Stock
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
Article By: Zacks Investment Research
Sunday, April 28, 2024 4:00 PM EDT
The first-quarter 2024 earnings season picked up pace this week, with Merck, Sanofi, Novartis, and AstraZeneca announcing their first-quarter results. Three of the four companies beat estimates for both earnings and sales in the first quarter.
In this article: AZN, JNJ, MRK, NVS, SNY
Read
3 Under-The-Radar Stocks With Positive Potential
Video By: Rick Ratchford
Sunday, April 21, 2024 12:42 PM EDT
In this video, I review some recent trades and discuss three overlooked stocks that may have massive potential.
In this video: MRK, SCHW, VZ Also: WFC
Watch
Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities
Article By: ChinaBio® Today
Saturday, March 23, 2024 2:00 PM EDT
Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Meanwhile, Novo Nordisk announced plans to invest $556 million to expand its Tianjin city production facility.
In this article: MRK, NVO, BGNE, WXXWY, IVBXF, WUXIF Also: NVS, CTLT
Read
Common Investing Mistake: Income Obsession (& More)
Article By: The Dividend Guy
Thursday, December 28, 2023 8:27 PM EDT
A common investing mistake is income obsession. Others are holding too many stocks and focusing on valuation to know if the price of a stock is right. Sounds familiar? Any of these mistakes hurts your portfolio. Luckily, you can fix it.
In this article: LMT, MRK, PFE, V, WMT, MSFT, SBUX, ABBV
Read
Three Solid Stocks That Still Have Plenty Of Growth Left
Article By: The Tokenist
Monday, November 20, 2023 5:07 PM EDT
The key ingredient is to find companies with sound fundamentals that aren’t appreciated as they should be. More so if their long-term growth is not fully accounted for.
In this article: MRK, ROK, MSFT
Read
All Posts

Latest Tweets for $MRK

No tweets yet!

PARTNER HEADLINES

$MRK

Comments Status Updates
OncoSec Raising Its Profile In Fight Against Cancer
Harry Goldstein • 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer
Alexis Renault • 9/6/2017 4:08:15 PM

Thanks for this info, @[Terry Chrisomalis](user:5023). Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan • 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 3 of 3 comments